Texas wins part of settlement against drug company

Texas will get $11.37 million as its share of a settlement with a pharmaceutical company that was being sued for deceptive marketing of antipsychotic drugs.

The company, Janssen Pharmaceuticals Inc. which is a subsidiary of New Brunswick, N.J.-based Johnson & Johnson, must pay a total of $181 million as part of the settlement but admits to no wrongdoing or violation of the law.

Texas Attorney General Greg Abbott joined with attorneys general in 36 other states four years ago to pursue the lawsuit.